Authors: María Velasco; Gerardo Rojo-Marcos; Emilio Merlo Pich; Emmanuel Bottieau; Silva Tommasini; Guido Calleri; Andrea Angheben; José Ramos; Matthieu Mechain; Tomas Jelinek; Christophe Rapp; Ron H Behrens; Maurizio Iannucelli; Antonella Bacchieri; Stephan Duparc; Nicolas Vignier; Zeno Bisoffi; Hans-Dieter Nothdurft; Yann Bourhis; Giovan Giuseppe Mattera; Olivier Bouchaud; Azucena Bardají; Charlotte Martin; Joaquín Salas-Coronas; Christoph Hatz; Leo G. Visser

Venue: Malaria Journal

Type: Publication

Abstract: Abstract BackgroundEuropean travelers are exposed to imported malaria and may be affected by co-existing morbidities. In this context, the safety profile, especially cardiac issues, of artenimol (previously dihydroartemisinin)-piperaquine (APQ) Eurartesim® during treatment of uncomplicated falciparum malaria is not adequately described due to the lack of longitudinal studies in this population. The present study was conducted to partially fill this gap.MethodsParticipants were recruited through Health Care Provider’s Safety Registry in 15 ce... (read more)

DOI: 10.21203/rs.3.rs-138999/v1